🇺🇸 FDA
Patent

US 12161755

Sustained release device for treatment of Parkinson's disease and other disorders

granted A61KA61K31/198A61K47/12

Quick answer

US patent 12161755 (Sustained release device for treatment of Parkinson's disease and other disorders) held by Regents of the University of Minnesota expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/198, A61K47/12, A61K9/006, A61K9/0065